(Q38398188)

2 September 2017

title

Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor (English)

1 reference

2 September 2017

1

Jens Schittenhelm

0 references

Bence Sipos

8

Bence Sipos

0 references

Falko Fend

6

Falko Fend

0 references

Richard Meyermann

5

Richard Meyermann

1 reference

2 September 2017

Marcos Soares Tatagiba

4

Marcos Tatagiba

1 reference

2 September 2017

Esther I Schwab

2

1 reference

2 September 2017

Jan Sperveslage

3

1 reference

2 September 2017

Simon L Goodman

7

1 reference

2 September 2017

publication date

1 March 2013

1 reference

Journal of Neuropathology & Experimental Neurology

2 September 2017

published in

1 reference

2 September 2017

volume

72

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

194-210

1 reference

Structure and mechanics of integrin-based cell adhesion.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

TGFβ: a sleeping giant awoken by integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

The role of integrins in glioma biology and anti-glioma therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Defining the role of integrin alphavbeta6 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Important role of integrins in the cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

The role of alpha v-integrins in tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Role of integrins in cancer: survey of expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Integrins as therapeutic targets: lessons and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Integrins as therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Vascular integrins: therapeutic and imaging targets of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Genetic pathways to primary and secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Rembrandt: helping personalized medicine become a reality through integrative translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Targeting integrins in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Automated analysis and detailed quantification of biomedical images using Definiens Cognition Network Technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Pro-apoptotic role of integrin β3 in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Generation of a monoclonal antibody directed against a human cell substrate adhesion molecule and the expression of the antigen in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Integrin signaling and lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Expression of glial fibrillary acidic protein, actin, fibronectin and factor VIII antigen in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

A mosaic mouse model of astrocytoma identifies alphavbeta8 integrin as a negative regulator of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Synaptic and glial localization of the integrin alphavbeta8 in mouse and rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Vascular development of the brain requires beta8 integrin expression in the neuroepithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Beta8 integrin regulates neurogenesis and neurovascular homeostasis in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3182851019

10.1097/NEN.0B013E3182851019

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference